menu search

Jounce Therapeutics Announces Closing of Tender Offer

Jounce Therapeutics Announces Closing of Tender Offer
Stockholders to Receive $1.85 Per Share in Cash Plus Contingent Value Rights CAMBRIDGE, Mass., May 03, 2023 (GLOBE NEWSWIRE) — Jounce Therapeutics, Inc. (NASDAQ: JNCE) (“Jounce” or the “Company”), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers, today announced that Concentra Biosciences, LLC (“Concentra”), through its wholly […] The post Jounce Therapeutics Announces Closing of Tender Offer appeared first on ForexTV... Read More
Posted: May 4 2023, 00:35
Author Name: forextv
Views: 101943

Search within

Pages Search Results: